Tecton Ketones

Tecton Ketones is a science-driven nutritional supplement company specializing in bioidentical exogenous ketone products for athletes, high-performance professionals, and individuals focused on metabolic health. The company's flagship ingredient, R3HBG, is a bioidentical form of beta-hydroxybutyrate — the same ketone molecule the human liver produces during fasting or intense exercise — delivered via a patented liposomal shell designed to survive digestion and reach the bloodstream intact. This proprietary delivery mechanism distinguishes Tecton from conventional exogenous ketone products, which the company asserts largely fail to absorb effectively and often cause gastrointestinal distress.

The development of R3HBG spans more than a decade, tracing its origins to DARPA-funded research on human resilience in the early 2000s and subsequent academic collaboration with institutions including the University of Oxford, the National Institutes of Health, and Georgia Tech. The patented liposomal delivery system was developed in partnership with the University of Missouri. In 2024, Tecton filed a New Dietary Ingredient (NDI) notification with the FDA under filing number 1354, securing regulatory recognition for R3HBG as one of the few ketone ingredients with such standing.

Tecton's current product portfolio includes four formulations: EDGE Caffeine, a clean energy product combining R3HBG with caffeine; EDGE Electrolytes, a performance hydration product; Locked Cognition, a cognitive support formula; and GLP-1 Activator, a metabolic health supplement. Each product references the R3HBG molecule as a central functional ingredient, positioning ketones not merely as a fitness aid but as a multi-application fuel source for energy, focus, hydration, and metabolism.

The company holds NSF Certified for Sport certification on its EDGE product line, a rigorous third-party standard widely respected in professional and elite athletic contexts. All products undergo independent laboratory testing on every batch, and the company publishes full ingredient transparency — no proprietary blends — alongside references to more than 50 peer-reviewed studies. The brand has been endorsed by the 2025 Hyrox World Champion, who competed across the full 2025 season fueled by R3HBG.

Tecton's leadership includes Chief Research Officer and founder Mike Chesne and co-founder Dr. Kevin Foley, a neurosurgery professor and Chairman of Semmes-Murphey Clinic at the University of Tennessee. The advisory team includes scientists, medical professionals, and performance experts. The company positions itself as a research-first brand that prioritizes scientific rigor, regulatory compliance, and third-party verification over speed-to-market, reflecting a deliberate development philosophy spanning from lab bench to commercial product.